Jimmy’s practice focuses on the representation of domestic and international private investment funds, including venture capital funds, private equity funds, hybrid funds, fund of funds, secondary funds, and other investment advisory businesses in connection with their formation, operation and investment activities.
Cooley advised Chemistry, an early-stage venture firm that leads investments in standout software companies at the Seed and Series A stages, on its $350 million debut fund, Chemistry Fund 1.
Cooley advised A* – an early-stage venture capital firm leading the shift from transactional capital to meaningful partnerships – on its $315 million oversubscribed Fund II.
Cooley advised Refactor Capital, a venture capital firm focused on early-stage investments in companies in bio, climate and hard tech innovation, on its $50 million fourth fund.
Andreessen Horowitz Closes $7.2 Billion in New Funds
April 16, 2024
Cooley represented Andreessen Horowitz (a16z), a Silicon Valley-based venture capital firm that backs bold entrepreneurs building the future through technology, on the closing of $7.2 billion for the following new funds: American Dynamism ($600 million), Applications ($1 billion), Games ($600 million), Infrastructure ($1.25 billion) and Growth ($3.75 billion).
